Skip to content

Drug interactions

Indacaterol-glycopyrronium + Pentamidine

Severity: Major

Indacaterol-glycopyrronium and Pentamidine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pentamidine can prolong the QT interval and cause torsades de pointes, and beta-2 agonists can add to cardiac excitability and lower potassium. Combined use may increase arrhythmic risk.

What this interaction means in plain words

Indacaterol-glycopyrronium and Pentamidine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Indacaterol-glycopyrronium belongs to Respiratory; Pentamidine belongs to Anti Parasitic.

Evidence level: Moderate

Why it happens

Additive QT prolongation with possible beta-agonist related hypokalemia.

What to do

Check baseline ECG, potassium and magnesium, and correct abnormalities before use. Monitor QTc during the pentamidine course or choose an alternative if feasible.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Pentamidine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol-glycopyrronium with Pentamidine?

MediHelp rates the interaction as major. Indacaterol-glycopyrronium and Pentamidine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pentamidine can prolong the QT interval and cause torsades de pointes, and beta-2 agonists can add to cardiac excitability and lower potassium. Combined use may increase arrhythmic risk.

How serious is the interaction between Indacaterol-glycopyrronium and Pentamidine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check baseline ECG, potassium and magnesium, and correct abnormalities before use. Monitor QTc during the pentamidine course or choose an alternative if feasible.

What other medicines interact with Indacaterol-glycopyrronium?

MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in